The recently published FLOW trial, which specifically targeted T2DM patients with CKD and used kidney-specific primary endpoints, has solidified the efficacy of GLP-1 RAs in slowing CKD progression [58]
If your current pharmacy is winding down, a licensed healthcare provider may determine, after a review of your records, that you may be better suited for a new treatment plan
The most common adverse reactions reported in clinical trials include nausea, vomiting, diarrhea, abdominal pain, and constipation, occurring in more than 5% of patients
[16] Rostami R., Aghasi M.R., Mohammadi A., Nourooz-Zadeh J
Cardiovascular Health: B12 works with other B vitamins to lower homocysteine, an amino acid that, at high levels, increases the risk of heart disease